For: | Micheu MM. Moving forward on the pathway of cell-based therapies in ischemic heart disease and heart failure – time for new recommendations? World J Stem Cells 2019; 11(8): 445-451 [PMID: 31523365 DOI: 10.4252/wjsc.v11.i8.445] |
---|---|
URL: | https://www.wjgnet.com/1948-0210/full/v11/i8/445.htm |
Number | Citing Articles |
1 |
Khawaja Husnain Haider. Priming mesenchymal stem cells to develop “super stem cells”. World Journal of Stem Cells 2024; 16(6): 623-640 doi: 10.4252/wjsc.v16.i6.623
|
2 |
Mathieu Rheault-Henry, Ian White, Rony Atoui. Handbook of Stem Cell Therapy. 2022; : 1 doi: 10.1007/978-981-16-6016-0_16-1
|
3 |
Mathieu Rheault-Henry, Ian White, Rony Atoui. Handbook of Stem Cell Therapy. 2022; : 471 doi: 10.1007/978-981-19-2655-6_16
|
4 |
Mathieu Rheault-Henry, Ian White, Diya Grover, Rony Atoui. Stem cell therapy for heart failure: Medical breakthrough, or dead end?. World Journal of Stem Cells 2021; 13(4): 236-259 doi: 10.4252/wjsc.v13.i4.236
|
5 |
Babak Arjmand, Mina Abedi, Maryam Arabi, Sepideh Alavi-Moghadam, Mostafa Rezaei-Tavirani, Mahdieh Hadavandkhani, Akram Tayanloo-Beik, Ramin Kordi, Peyvand Parhizkar Roudsari, Bagher Larijani. Regenerative Medicine for the Treatment of Ischemic Heart Disease; Status and Future Perspectives. Frontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.704903
|